The results of the present study clearly show that IL-15 DCs, but not conventional IL-4 DCs, can induce an activated phenotype in NK cells and enhance NK cell cytotoxicity against both NK-sensitive as well as NK-insensitive tumor cells. Here, IL15 is linked to neoplasm.